Thursday, October 9, 2025

Latest

Medipharm Labs Delays Q1 Financials, Announces Inventory Impairments

Medipharm Labs (TSX: LABS) this morning announced that it will be delaying its first quarter financial results, with the company giving a blanket statement that it expects to file by the end of June. Furthermore, the company also announced that it will be conducting impairments on inventory among other items as a result of the ongoing pandemic.

With respect to inventory, Medipharm this morning let it be known that the company is expecting to impair anywhere from $10 to $15 million within its first quarter financials. The company blamed the impairment on reduced demand due to the current coronavirus pandemic. Overall, a number of reasons were cited that lead up to the announcement within the news release including:

  • Reduced staff at provincial distributors and private retailers, which the company claims resulted in reduced purchase orders and delivery availability, impacting white label sales.
  • Delays in anticipated expansions of retail channels and slower licensing of cannabis derivative businesses.
  • Producers being slower to implement capabilities to convert bulk extract to finished goods due to operational slowdowns.

These factors were all blamed for oversupply conditions of bulk extract product within the Canadian market, including subsequent lower selling price points and volumes, which ultimately resulted in these writedowns occurring. The company provided no guidance on revenue figures.

Medipharm Labs reported product inventories of $51.5 million as of December 31, 2019. The company last traded at $1.54 on the TSX.


Information for this briefing was found via Sedar and MediPharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Medipharm Labs Reports Revenues of $31 million for Second Quarter

Medipharm Labs (TSX: LABS) filed its second quarter earnings after the bell this evening, reporting...

Monday, August 12, 2019, 05:35:41 PM

Medipharm Labs Closes $33.4 Million Bought Deal Financing

Medipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then...

Friday, March 5, 2021, 09:12:09 AM

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

Medipharm Labs Increases Bought Deal To $29.0 Million

Medipharm Labs (TSX: LABS) has increased the size of the bought deal financing announced last...

Tuesday, March 2, 2021, 09:26:39 AM

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM